175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series
Publication
, Conference
Lick, SD; Kislingbury, KK; Kollar, AC; Barbagelata, NA; Koerner, MM; Valentine, VG
Published in: The Journal of Heart and Lung Transplantation
February 2010
Duke Scholars
Published In
The Journal of Heart and Lung Transplantation
DOI
ISSN
1053-2498
Publication Date
February 2010
Volume
29
Issue
2
Start / End Page
S63 / S63
Publisher
Elsevier BV
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lick, S. D., Kislingbury, K. K., Kollar, A. C., Barbagelata, N. A., Koerner, M. M., & Valentine, V. G. (2010). 175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series. In The Journal of Heart and Lung Transplantation (Vol. 29, pp. S63–S63). Elsevier BV. https://doi.org/10.1016/j.healun.2009.11.185
Lick, S. D., K. K. Kislingbury, A. C. Kollar, N. A. Barbagelata, M. M. Koerner, and V. G. Valentine. “175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series.” In The Journal of Heart and Lung Transplantation, 29:S63–S63. Elsevier BV, 2010. https://doi.org/10.1016/j.healun.2009.11.185.
Lick SD, Kislingbury KK, Kollar AC, Barbagelata NA, Koerner MM, Valentine VG. 175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series. In: The Journal of Heart and Lung Transplantation. Elsevier BV; 2010. p. S63–S63.
Lick, S. D., et al. “175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series.” The Journal of Heart and Lung Transplantation, vol. 29, no. 2, Elsevier BV, 2010, pp. S63–S63. Crossref, doi:10.1016/j.healun.2009.11.185.
Lick SD, Kislingbury KK, Kollar AC, Barbagelata NA, Koerner MM, Valentine VG. 175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series. The Journal of Heart and Lung Transplantation. Elsevier BV; 2010. p. S63–S63.
Published In
The Journal of Heart and Lung Transplantation
DOI
ISSN
1053-2498
Publication Date
February 2010
Volume
29
Issue
2
Start / End Page
S63 / S63
Publisher
Elsevier BV
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology